dc.contributor.author
Spies, Claudia
dc.contributor.author
Luetz, Alawi
dc.contributor.author
Lachmann, Gunnar
dc.contributor.author
Renius, Markus
dc.contributor.author
Haefen, Clarissa von
dc.contributor.author
Wernecke, Klaus-Dieter
dc.contributor.author
Bahra, Marcus
dc.contributor.author
Schiemann, Alexander
dc.contributor.author
Paupers, Marco
dc.contributor.author
Meisel, Christian
dc.date.accessioned
2018-06-08T03:33:40Z
dc.date.available
2016-01-18T12:22:16.053Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/15449
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-19637
dc.description.abstract
Purpose Surgical patients are at high risk for developing infectious
complications and postoperative delirium. Prolonged infections and delirium
result in worse outcome. Granulocyte-macrophage colony-stimulating factor (GM-
CSF) and influenza vaccination are known to increase HLA-DR on monocytes and
improve immune reactivity. This study aimed to investigate whether GM-CSF or
vaccination reverses monocyte deactivation. Secondary aims were whether it
decreases infection and delirium days after esophageal or pancreatic resection
over time. Methods In this prospective, randomized, placebo-controlled,
double-blind, double dummy trial setting on an interdisciplinary ICU of a
university hospital 61 patients with immunosuppression (monocytic HLA-DR
[mHLA-DR] <10,000 monoclonal antibodies [mAb] per cell) on the first day after
esophageal or pancreatic resection were treated with either GM-CSF (250
μg/m2/d), influenza vaccination (Mutagrip 0.5 ml/d) or placebo for a maximum
of 3 consecutive days if mHLA-DR remained below 10,000 mAb per cell. HLA-DR on
monocytes was measured daily until day 5 after surgery. Infections and
delirium were followed up for 9 days after surgery. Primary outcome was HLA-DR
on monocytes, and secondary outcomes were duration of infection and delirium.
Results mHLA-DR was significantly increased compared to placebo (p < 0.001)
and influenza vaccination (p < 0.001) on the second postoperative day.
Compared with placebo, GM-CSF-treated patients revealed shorter duration of
infection (p < 0.001); the duration of delirium was increased after
vaccination (p = 0.003). Conclusion Treatment with GM-CSF in patients with
postoperative immune suppression was safe and effective in restoring monocytic
immune competence. Furthermore, therapy with GM-CSF reduced duration of
infection in immune compromised patients. However, influenza vaccination
increased duration of delirium after major surgery.
en
dc.rights.uri
http://creativecommons.org/licenses/by/4.0/
dc.subject.ddc
600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit
dc.title
Influence of Granulocyte-Macrophage Colony-Stimulating Factor or Influenza
Vaccination on HLA-DR, Infection and Delirium Days in Immunosuppressed
Surgical Patients
dc.type
Wissenschaftlicher Artikel
dcterms.bibliographicCitation
PLoS ONE. - 10 (2015), 12, Artikel Nr. e0144003
dc.title.subtitle
Double Blind, Randomised Controlled Trial
dcterms.bibliographicCitation.doi
10.1371/journal.pone.0144003
dcterms.bibliographicCitation.url
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0144003
refubium.affiliation
Charité - Universitätsmedizin Berlin
de
refubium.mycore.fudocsId
FUDOCS_document_000000023736
refubium.note.author
Der Artikel wurde in einer Open-Access-Zeitschrift publiziert.
refubium.resourceType.isindependentpub
no
refubium.mycore.derivateId
FUDOCS_derivate_000000005854
dcterms.accessRights.openaire
open access